Cargando…
Pancreatic cancer: Surgery is a feasible therapeutic option for elderly patients
BACKGROUND: Compromised physiological reserve, comorbidities, and the natural history of pancreatic cancer may deny pancreatic resection from elderly patients. We evaluated outcomes of elderly patients amenable to pancreatic surgery. METHODS: The medical records of all patients who underwent pancrea...
Autores principales: | Lahat, Guy, Sever, Ronen, Lubezky, Nir, Nachmany, Ido, Gerstenhaber, Fabian, Ben-Haim, Menahem, Nakache, Richard, Koriansky, Josef, Klausner, Josef M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039615/ https://www.ncbi.nlm.nih.gov/pubmed/21272335 http://dx.doi.org/10.1186/1477-7819-9-10 |
Ejemplares similares
-
Early reoperation following pancreaticoduodenectomy: impact on morbidity, mortality, and long-term survival
por: Lessing, Yonatan, et al.
Publicado: (2019) -
Number of evaluated lymph nodes and positive lymph nodes, lymph node ratio, and log odds evaluation in early-stage pancreatic ductal adenocarcinoma: numerology or valid indicators of patient outcome?
por: Lahat, G., et al.
Publicado: (2016) -
Adjuvant FOLFIRINOX in Patients with Resectable Pancreatic Cancer Is Effective but Rarely Feasible in Real Life: Is Neoadjuvant FOLFIRINOX a Better Option?
por: Maman, Yossi, et al.
Publicado: (2023) -
The Role and Limitations of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography (FDG-PET) Scan and Computerized Tomography (CT) in Restaging Patients with Hepatic Colorectal Metastases Following Neoadjuvant Chemotherapy: Comparison with Operative and Pathological Findings
por: Lubezky, Nir, et al.
Publicado: (2007) -
SAT-180 Adrenocortical Carcinoma - A Tertiary Center’s Recent 5-Year Experience
por: Ehrenwald, Michal, et al.
Publicado: (2020)